BNP Paribas Asset Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$190K Buy
3,633
+753
+26% +$45.2K ﹤0.01% 1370
2025
Q4
$169K Buy
2,880
+268
+10% +$16.3K ﹤0.01% 1366
2025
Q3
$145K Sell
2,612
-59,110
-96% -$3.17M ﹤0.01% 802
2025
Q2
$3.18M Buy
61,722
+49,301
+397% +$2.48M 0.01% 641
2025
Q1
$728K Buy
12,421
+2,640
+27% +$179K ﹤0.01% 777
2024
Q4
$705K Buy
9,781
+2,911
+42% +$214K ﹤0.01% 798
2024
Q3
$549K Sell
6,870
-447
-6% -$33.6K ﹤0.01% 807
2024
Q2
$524K Sell
7,317
-1,390
-16% -$102K ﹤0.01% 873
2024
Q1
$613K Buy
8,707
+1,005
+13% +$71.9K ﹤0.01% 798
2023
Q4
$594K Buy
7,702
+1,081
+16% +$71.2K ﹤0.01% 769
2023
Q3
$451K Buy
6,621
+389
+6% +$30.7K ﹤0.01% 790
2023
Q2
$509K Sell
6,232
-752
-11% -$60.4K ﹤0.01% 777
2023
Q1
$518K Buy
6,984
+644
+10% +$49.6K ﹤0.01% 803
2022
Q4
$525K Buy
6,340
+1,700
+37% +$135K ﹤0.01% 831
2022
Q3
$329K Buy
+4,640
New +$401K ﹤0.01% 844
2022
Q1
Sell
-2,760
Closed -$357K 934
2021
Q4
$357K Buy
2,760
+64
+2% +$7.85K ﹤0.01% 853
2021
Q3
$327K Buy
2,696
+716
+36% +$87.1K ﹤0.01% 830
2021
Q2
$223K Buy
+1,980
New +$208K ﹤0.01% 881
2019
Q3
Sell
-7,908
Closed -$412K 884
2019
Q2
$412K Sell
7,908
-476
-6% -$24K ﹤0.01% 789
2019
Q1
$416K Hold
8,384
﹤0.01% 821
2018
Q4
$297K Buy
8,384
+3,200
+62% +$134K ﹤0.01% 851
2018
Q3
$265K Sell
5,184
-1,068
-17% -$47.3K ﹤0.01% 874
2018
Q2
$231K Buy
+6,252
New +$239K ﹤0.01% 920

Other funds holding TECH

BNP Paribas Asset Management's TECH Position: Q1 2026 in Review

BNP Paribas Asset Management increased its Bio-Techne (TECH) stake by 26% in Q1 2026, buying an estimated $45.2K and bringing the position to 3,633 shares worth $190K. The position accounts for ﹤0.01% of the portfolio, ranked #1370.

BNP Paribas Asset Management first reported a position in TECH in Q2 2018 and has held it in 23 quarters since. The position peaked at $3.18M in Q2 2025. 584 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • BNP Paribas Asset Management held 3,633 shares of Bio-Techne worth $190K as of Q1 2026.
  • BNP Paribas Asset Management bought 753 Bio-Techne shares in Q1 2026, an estimated $45.2K.
  • Bio-Techne made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #1370 holding.
  • BNP Paribas Asset Management first reported a position in Bio-Techne in Q2 2018 and has held it in 23 quarters since.
  • BNP Paribas Asset Management's Bio-Techne position peaked at $3.18M in Q2 2025.
  • 584 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.